Wednesday, March 21, 2012

Myoscience grabs $33M, targets Europe for cold therapy for wrinkles

Aesthetic medical device company Myoscience Inc. scored $33 million in a Series D financing and said it expects another $12 million tranche.
The Redwood City-based company, one of a cluster of Bay Area drug and device companies focused on the personal care and vanity markets, will use the cash from the Series D round to sell its focused cold therapy, or FCT, in Europe to treat forehead wrinkles.

No comments:

Post a Comment